Dual effect of the phorbol ester TPA on arachidonic acid release from HeLa cells.
Article Details
- CitationCopy to clipboard
Kaszkin M, Espe U, Furstenberger G, Kinzel V
Dual effect of the phorbol ester TPA on arachidonic acid release from HeLa cells.
FEBS Lett. 1988 Jun 20;233(2):244-8. doi: 10.1016/0014-5793(88)80435-6.
- PubMed ID
- 3133247 [ View in PubMed]
- Abstract
The tumor promoter 12-O-tetradecanoylphorbol 13-acetate (TPA) induces release of arachidonic acid (AA) from HeLa cells with a maximum at 2-3 h. Subsequently the extracellular level of AA decreases. Cycloheximide (CH, 10(-5) M does not influence the release of AA, however, it causes the AA level to remain elevated. In the presence of TPA and CH (i) re-uptake of AA is not altered, (ii) re-incorporation of AA into phosphatidylinositol (and phosphatidylethanolamine) is largely increased, and (iii) the level of lysophosphatidylinositol is elevated. The latter two phenomena can be prevented by fluocinolone acetonide (10(-8) M), i.e. by inhibition of phospholipase A2 (PLA2). These data point to a continuously elevated PLA2 activity in the presence of TPA and CH. The phorbol ester appears to induce a proteinaceous principle which diminishes PLA2 activity.
DrugBank Data that Cites this Article
- Drug Targets
Drug Target Kind Organism Pharmacological Action Actions Fluocinolone acetonide Phospholipase A2 Protein Humans UnknownInhibitorDetails